recombinant granulocyte colony stimulating factor (G-CSF) [HSA:1440] [KO:K05423]
Reducing neutropenia and the incidence of infecton in patients with cancer
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA19 Eflapegrastim
D11188 Eflapegrastim (USAN/INN) <US>
USP drug classification [BR:br08302]
Immunological Agents
Immunostimulants
Colony-stimulating Factors
Eflapegrastim
D11188 Eflapegrastim (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
D11188 Eflapegrastim
Drug classes [BR:br08332]
Immunological agent
DG01753 Colony stimulating factor
D11188 Eflapegrastim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D11188 Eflapegrastim (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11188
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11188
